LeMaitre ( LMAT ) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LeMaitre ( LMAT ) Q2 Revenue Jumps 15%
LeMaitre Vascular ( NASDAQ:LMAT ) , a medical device company focused on vascular surgeons, reported its latest quarterly earnings after the bell on August 5, 2025. The company delivered GAAP results ahead of expectations, posting GAAP earnings per share of $0.60, above the anticipated $0.57 ( ...
LeMaitre Vascular ( LMAT ) Beats Q2 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of +5.26% and +2.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - LeMaitre Vascular ( NASDAQ:LMAT ) , Anteris Technologies Glb ( NASDAQ:AVR )
MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 ( GLOBE NEWSWIRE ) -- Anteris Technologies Global Corp. ( Anteris or the Company ) AVRAVR ) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, ...
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 ( GLOBE NEWSWIRE ) -- Anteris Technologies Global Corp. ( Anteris or the Company ) ( NASDAQ: AVR, ASX: AVR ) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore ...
Aortic Stent Graft Market Size is Expected to Reach $4.03 Billion by 2031, Driven by Aortic Aneurysms and Shift Toward Minimally Invasive Procedures | The Insight Partners
US & Canada, May 23, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the aortic stent graft market is witnessing significant growth owing to the rising prevalence of aortic aneurysms and the shift toward minimally invasive procedures.
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., May 05, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las Vegas, NV.
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
BURLINGTON, Mass., May 05, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las ...
LeMaitre Vascular ( LMAT ) Lags Q1 Earnings Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -4% and 3.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio - Elutia ( NASDAQ:ELUT )
Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 ( GLOBE NEWSWIRE ) -- Elutia Inc.
BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care
BDX's AI-based advanced hemodynamic monitoring platform is likely to aid clinicians to address blood flow instability and pressure in critical situations and improve patient outcomes.
FitLife Brands ( FTLF ) Surges 13.1%: Is This an Indication of Further Gains?
FitLife Brands (FTLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care
Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room.
LeMaitre ( LMAT ) Soars 7.7%: Is Further Upside Left in the Stock?
LeMaitre (LMAT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., April 07, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close.
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
BURLINGTON, Mass., April 07, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day ...
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., April 01, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 01, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
3 Reasons Growth Investors Will Love LeMaitre ( LMAT )
LeMaitre (LMAT) could produce exceptional returns because of its solid growth attributes.
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
GARDNER, Mass., March 20, 2025 ( GLOBE NEWSWIRE ) -- Precision Optics Corporation, Inc. ( NASDAQ: POCI ) , a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Joseph P. "JJ" Pellegrino, ...
Down -15.37% in 4 Weeks, Here's Why LeMaitre ( LMAT ) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for LeMaitre (LMAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
3 Best Earnings Growth Stocks to Buy in March: CAKE, LMAT, HURN
The Cheesecake Factory, LeMaitre Vascular and Huron Consulting Group are currently displaying superb earnings growth.
Ensign Group Expands Healthcare Portfolio With Key Acquisitions
ENSG acquires skilled nursing and senior living facilities across four states, expanding its U.S. footprint and bringing higher revenues for its Skilled Services segment.
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year ...
New Strong Buy Stocks for March 4th
OPCH, LMAT, C, FFIN and IBCP have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2025.
LeMaitre to Participate at Upcoming Investor Conferences in March - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., March 03, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that management will be participating in three upcoming investor conferences in March. 37th Annual ROTH Conference Monday, March 17, 2025 The Laguna Cliffs Marriott, Dana Point, CA Management ...
LeMaitre to Participate at Upcoming Investor Conferences in March
BURLINGTON, Mass., March 03, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that management will be participating in three upcoming investor conferences in March.
LeMaitre ( LMAT ) Upgraded to Buy: Here's What You Should Know
LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LeMaitre Vascular ( LMAT ) Meets Q4 Earnings Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of 0% and 0.76%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics ( HAE ) Q3 Earnings Meet Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of 0% and 1.30%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
BURLINGTON, Mass., Jan. 27, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the ...
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
The blood testing process integrating BD's MiniDraw System with Babson's BetterWay technologies is likely to lower common barriers to testing and improve patient outcomes.
LeMaitre Vascular Prices $150 Million Convertible Senior Notes - LeMaitre Vascular ( NASDAQ:LMAT )
BOSTON, Dec. 16, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( "LeMaitre" ) LMAT today announced the pricing of its offering of $150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 ( the "notes" ) in a private offering ( the "offering" ) to qualified ...
STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot
Stereotaxis' latest regulatory approval in China is likely to offer a minimally-invasive treatment solution for complex arrhythmia patients and improve global cardiovascular care.
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
BOSTON, Dec. 16, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( "LeMaitre" ) ( Nasdaq: LMAT ) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate principal amount of Convertible Senior Notes due 2030 ( the "notes" ) in a private offering ( ...
RMD vs. LMAT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either ResMed ( RMD Quick QuoteRMD - ) or LeMaitre Vascular ( LMAT Quick QuoteLMAT - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
LeMaitre to Participate at Upcoming Investor Conferences in December - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that it is participating in two upcoming investor conferences in December.
LeMaitre to Participate at Upcoming Investor Conferences in December
BURLINGTON, Mass., Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that it is participating in two upcoming investor conferences in December.
Community Health to Sell Florida Hospital to AdventHealth for $265M
CYH enters an agreement to sell ShorePoint Health System assets in Florida for $265 million, advancing its strategy to shed non-core facilities and enhance focus on growth areas.
Bridget Ross At LeMaitre Vascular Decides to Exercises Options Worth $276K - LeMaitre Vascular ( NASDAQ:LMAT )
On November 19, it was revealed in an SEC filing that Bridget Ross, Board Member at LeMaitre Vascular LMAT executed a significant exercise of company stock options. What Happened: Ross, Board Member at LeMaitre Vascular, exercised stock options for 3,750 shares of LMAT stock.
LeMaitre to Participate at Upcoming Investor Conferences in November - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., Nov. 01, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. LMAT announced today that management will be participating in three upcoming investor conferences in November. Terranea Resort, Rancho Palos Verdes, CA David Roberts, President, will present at 7:15 AM PT
LeMaitre to Participate at Upcoming Investor Conferences in November
BURLINGTON, Mass., Nov. 01, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that management will be participating in three upcoming investor conferences in November.
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday - Apple ( NASDAQ:AAPL ) , Amazon.com ( NASDAQ:AMZN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Rosenblatt raised Apple Inc. AAPL price target from $261 to $262. Rosenblatt analyst Barton Crockett ...
LeMaitre Vascular ( LMAT ) Surpasses Q3 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of 11.36% and 2.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Q3 2024 Financial Results
BURLINGTON, Mass., Oct. 31, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre ( Nasdaq:LMAT ) , a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance.
BAX or LMAT: Which Is the Better Value Stock Right Now?
BAX vs. LMAT: Which Stock Is the Better Value Option?
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
BURLINGTON, Mass., Oct. 15, 2024 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same ...
